Seeking Alpha

Avon (AVP) has held serious talks about acquiring Obagi Medical Products (OMPI), although it...

Avon (AVP) has held serious talks about acquiring Obagi Medical Products (OMPI), although it hasn't yet bid high enough, writes SA author Scott Matusow, while L'Oreal (LRLCY.PK) is also showing interest. Matusow reckons that with institutions owning about 90% of the company, and with "the majority of them" wanting Obagi sold," a deal will happen soon.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs